Stock listing
A11664 Stock Price, News, Filings & Events — Amphastar Pharmaceuticals, Inc.
Selected listing: A11664 · LSX · EUR · DE
This page tracks Amphastar Pharmaceuticals, Inc.'s A11664:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A11664:LSX. A11664:LSX is the stock-level entry point for investors researching Amphastar Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A11664:LSX
- Asset type
- Stock
- Market cap
- $936.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Amphastar Pharmaceuticals, Inc. A11664:LSX stock context
This page tracks Amphastar Pharmaceuticals, Inc.'s A11664:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A11664:LSX. A11664:LSX is the stock-level entry point for investors researching Amphastar Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026
July 29, 2026
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
May 27, 2026
Amphastar Pharmaceuticals : Q1 Financial Results (news)
May 8, 2026
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026
May 7, 2026
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference
May 6, 2026
Amphastar Pharmaceuticals, Inc. earnings calls
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Research Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for A11664:LSX.
Amphastar Pharmaceuticals, Inc. company profile
View the public company page for Amphastar Pharmaceuticals, Inc. on 6ix.
Amphastar Pharmaceuticals, Inc. news
Read company news and market updates connected to Amphastar Pharmaceuticals, Inc..
Amphastar Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Amphastar Pharmaceuticals, Inc..
Alternate listings
AMPH:NASDAQ
US · USD
Alternate listing for Amphastar Pharmaceuticals, Inc.; the primary context on this page is A11664:LSX.
29A:GETTEX
DE · EUR
Alternate listing for Amphastar Pharmaceuticals, Inc.; the primary context on this page is A11664:LSX.
A11664:LS
DE · EUR
Alternate listing for Amphastar Pharmaceuticals, Inc.; the primary context on this page is A11664:LSX.
AMPH:BOATS
US · USD
Alternate listing for Amphastar Pharmaceuticals, Inc.; the primary context on this page is A11664:LSX.
29A:TRADEGATE
DE · EUR
Alternate listing for Amphastar Pharmaceuticals, Inc.; the primary context on this page is A11664:LSX.
29A:FWB
DE · EUR
Alternate listing for Amphastar Pharmaceuticals, Inc.; the primary context on this page is A11664:LSX.
29A:DUS
DE · EUR
Alternate listing for Amphastar Pharmaceuticals, Inc.; the primary context on this page is A11664:LSX.
29A:MUN
DE · EUR
Alternate listing for Amphastar Pharmaceuticals, Inc.; the primary context on this page is A11664:LSX.
29A:SWB
DE · EUR
Alternate listing for Amphastar Pharmaceuticals, Inc.; the primary context on this page is A11664:LSX.